Funding for this research was provided by:
the National Natural Science Foundation of China (81960613, 81660563)
Natural Science Foundation of Guangxi Province (2018GXNSFBA138003)
Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor (Gaungxi Medical University), Ministry of Education (GKE-ZZ202001)
Received: 19 November 2021
Accepted: 29 December 2021
First Online: 31 January 2022
: The animal study was reviewed and approved by the Guangxi Medical University Laboratory Animal Center [SYXKGUI 2020-0004]. The studies involving human participants were reviewed and approved by the Ethics Committee of Guangxi Medical University. The patients/participants provided their written informed consent to participate in this study.
: All authors have approved the manuscript for submission.
: The authors declare that they have no competing interests.